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ABSTRACT
Background We compared community- led versus an 
established community- based HIV self- testing (HIVST) 
model in rural Zimbabwe using a cluster- randomised trial.
Methods Forty village groups were randomised 1:1 
using restricted randomisation to community- led HIVST, 
where communities planned and implemented HIVST 
distribution for 4 weeks, or paid distribution (PD), where 
distributors were paid US$50 to distribute kits door- to- 
door over 4 weeks. Individual level primary outcomes 
compared household survey responses by arm 4 months 
post- intervention for: (1) newly diagnosed HIV during/
within 4 months following HIVST distribution, (2) linkage to 
confirmatory testing, pre- exposure prophylaxis or voluntary 
medical male circumcision during/within 4 months 
following HIVST distribution. Participants were not masked 
to allocation; analysis used masked data. Trial analysis 
used random- effects logistic regression.
Distribution costs compared: (1) community- led HIVST, 
(2) PD HIVST and (3) PD costs when first implemented in 
2016/2017.
Results From October 2018 to August 2019, 27 812 
and 36 699 HIVST kits were distributed in community- led 
and PD communities, respectively. We surveyed 11 150 
participants and 5683 were in community- led arm. New 
HIV diagnosis was reported by 211 (3.7%) community- led 
versus 197 (3.6%) PD arm participants, adjusted OR (aOR) 
1.1 (95% CI 0.72 to 1.56); 318 (25.9%) community- led 
arm participants linked to post- test services versus 361 
(23.9%) in PD arm, aOR 1.1 (95% CI 0.75 to 1.49.
Cost per HIVST kit distributed was US$6.29 and US$10.25 
for PD and community- led HIVST, both lower than 
2016/2017 costs for newly implemented PD (US$14.52). 
No social harms were reported.
Conclusions Community- led HIVST can perform as well 
as paid distribution, with lower costs in the first year. These 
costs may reduce with programme maturity/learning.
Trial registration number PACTR201811849455568.
INTRODUCTION
HIV self- testing (HIVST) is recommended 
as a testing strategy by WHO.1 Various 
models of distributing HIVST kits have been 
implemented and/or evaluated, including 
community- based, health facility- based, 
pharmacy, workplace, secondary distribu-
tion and distribution through programmes 
such as voluntary medical male circumcision 
(VMMC) and antenatal care.2–5 As has been 
found for provider- delivered community- 
based HIV testing services,6 7 there is evidence 
that community- based HIVST is acceptable8 9 
and can increase uptake of testing and linkage 
to HIV treatment, including among groups 
who typically have lower uptake of testing, 
such as men and young people.4 5 10 However, 
provision of community- based HIVST can 
be resource- intensive, particularly when kits 
are delivered door- to- door.11 As programmes 
prepare for full national scale up, there is 
need to identify and evaluate sustainable 
and/low cost models of providing HIVST 
in communities. A potential model is the 
community- led approach.
Community- led interventions are designed 
and implemented by communities, usually 
with support from programme imple-
menters.12 They have been used to drive 
various health interventions,12–15 with success 
depending on the extent to which communi-
ties take ownership of the intervention and 
are motivated by perceived community bene-
fits to take collective action towards ensuring 
implementation. Previous research on HIVST 
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distribution in rural areas found that briefly trained door- 
to- door paid HIVST community- based distributors were 
able to reach 50.3% of adults with detectable impact 
on demand for antiretroviral therapy (ART).10 A small 
incentive paid to increase post- test linkage did not moti-
vate distributors beyond that achieved by a fixed stipend, 
with distributors stating the importance of non- monetary 
drivers of job satisfaction such as standing in the commu-
nity and importance of the task, previously associated 
with successful unpaid community- led interventions. 
A community- led HIVST approach might be able to 
improve engagement of communities with awareness 
of HIV prevention messages, notably ‘U=U’ messaging 
around treatment- as- prevention that is particularly rele-
vant for HIVST given the adverse event profile for discor-
dant couples, and also pre- exposure prophylaxis (PrEP) 
and VMMC. The community- led approach may also target 
the distribution of kits towards people who need to test. 
Finally, community- led HIVST has potential to reduce 
resource requirements from the provider’s perspective.
We used a cluster- randomised trial design (because 
the intervention could only be implemented at commu-
nity level) to directly compare outcomes and costs of 
community- led HIVST with a more vertical approach 
of professionally- supervised paid community- based 
distributors, with the following primary objectives 
pertaining to the individual level: to determine the effect 
of community- led HIVST on (1) recent HIV diagnoses, 
(2) linkage to post- test HIV care and prevention services 
and (3) to compare the distribution costs of commu-
nity- led models against those of newly introduced and 
repeat rounds of paid distributor HIVST campaigns.11
METHODS
This research is part of the large portfolio of studies 
conducted by the Self Testing AfRica (STAR) Initiative, 
http://hivstarlshtmacuk/.16 Implementation of HIVST 
distribution was led by Population Services International 
(PSI) between October 2018 and August 2019, on a 
rolling campaign basis as we moved from one community 
to the next.
Population and setting
The study was conducted in Zimbabwe, a country with 
HIV prevalence of 12.9%.17 Zimbabwe Ministry of 
Health and Child Care provides decentralised HIV 
services across all levels of care, with facility- based and 
community- based support given by implementing part-
ners across many districts. Study implementation was 
done in six rural districts (Shamva, Muzarabani, Mutoko, 
Zvimba, Shurugwi and Umguza) in five provinces where 
PSI was implementing HIV testing services. Clusters 
were defined as headman units, an official administra-
tive subunit through which rural community- level activ-
ities are implemented in Zimbabwe. Because headman 
unit sizes varied, potentially eligible headmen units had 
to have at least three census enumeration areas (CEAs) 
within. We randomly selected one headman unit of at 
least 3 CEAs per ward, (figure 1). The minimum distance 
between each headman unit and its nearest neighbour 
was 20 km.
Study design
We conducted a cluster randomised trial comparing two 
HIVST distribution strategies, as summarised in figure 1. 
Headman units were randomised to either communi-
ty- led or paid HIVST distribution. Distribution was done 
over 4 weeks, with flexible distribution days and times 
according to distributor preference and social etiquette. 
In general distributors undertook distribution on several 
days of the week.
Trial outcomes were evaluated using household surveys 
4 months post- distribution to determine uptake of HIVST 
and linkage to post- test services.
Monthly clinic- level data of new ART initiations for all 
facilities across the six districts were also used to evaluate 
the impact of HIVST using a difference- in- differences 
design (6 months before HIVST distribution began, 
during and 3 months after). We conducted detailed 
costing of the community- led model and compared it 
with costs of the (1) the paid distributor model that was 
implemented during the study and, (2) a historical paid 
distributor model when first implemented in 2016/17.
Key questions
What is already known?
 ► Community- based HIV self- testing (HIVST) is feasible and accept-
able and improves uptake of testing by groups who would not oth-
erwise test.
 ► However, it is resource intensive and there is need to find lower cost 
models for community- based HIVST distribution.
 ► Community- led models have been successfully used to drive vari-
ous health interventions.
 ► They have potential to successfully implement community- based 
HIVST at lower cost.
 ► We compared community- led HIVST with an established 
community- based HIVST distribution model in rural Zimbabwe us-
ing a cluster- randomised trial.
What are the new findings?
 ► Communities were able to develop and implement their own HIVST 
models to produce outcomes that were comparable to those of a 
programme where HIVST kits were distributed by distributors who 
received stipends and professional support.
 ► The cost of distributing HIVST kits in the mature paid distributor 
model were lower than those of the community- led model.
 ► Of note, however, community- led distribution costs were lower than 
those of the paid distribution model when it was first introduced in 
2016–2017, indicating that as the programme matures the costs 
may come down.
What do the new findings imply?
 ► The community- led HIVST intervention is a promising model that 
can be integrated with local standard of care and for scale up of 
self- testing.
 ► Additional research can explore layering of different interventions 
that have potential to be driven by communities.




The unit of randomisation was the headman unit. Rando-
misation of headman units (1:1) by the study statistician 
(MN) was restricted to ensure balance across arms by 
district, distance from the centre of the headman unit 
to the nearest health facility and availability of PrEP at 
the nearest health facility. Out of all the possible combi-
nations, 100 000 randomisation options were generated 
at random and were subjected to the restriction criteria, 
resulting in 18 013 options, from which the final rando-
misation option was randomly selected by the statistician 
and communicated to the implementing team. No allo-
cation concealment was done.
Headman units and distributors could not be masked 
to study arm, but data and investigators were masked 
until analysis of primary outcomes was complete.
Community-led HIVST distribution (community-led arm)
The intervention was implemented at the headman unit 
level. Figure 2 illustrates the process followed to engage 
headman units, piloted in four headman units before 
the trial began. A detailed description of the interven-
tion according to the Template for Intervention Descrip-
tion and Replication (TIDieR) framework18 is given 
in figure 3. First, PSI met with community leadership 
to explain the concept of a community- led approach, 
including the potential benefits and challenges. It was 
Figure 1 Trial profile. EA, enumeration area; HIVST, HIV self- testing.
Figure 2 Process of engaging community- led HIVST clusters. HIVST, HIV self- testing; PSI, Population Services International.
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explained that headman units would need to invest 
their own resources, particularly time, with no financial 
compensation and that headman units and their leader-
ship could decline participation. Because community- 
level interventions typically follow a top- down approach, 
we obtained the leadership’s buy- in that they would not 
impose their ideas, but would support a truly communi-
ty- led intervention. Leadership was then asked to set up 
community- level meetings to facilitate engagement of 
PSI with the headman unit.
All headman unit members aged 16 years and above 
were invited to the first meeting (16 years being the 
minimum age for consenting to an HIV test in Zimbabwe) 
during which we introduced the concept of a commu-
nity- led model and described the importance of HIV 
testing and the concept of ART for preventing HIV trans-
mission.19 We explained that new HIV infections in their 
headman unit could be reduced by early HIV testing 
and linkage to ART. Other HIV prevention interventions 
(VMMC and PrEP) were also discussed.
Headman units were then tasked with designing their 
own models of distributing HIVST kits, ensuring that 
their models adhered to the following Ministry of Health 
guidelines: (1) no kits given to individuals younger than 
16 years, (2) no forced testing or results disclosure, (3) 
confidentially was to be upheld. Headman units were 
given 1 week for internal consultations, after which PSI 
visited the named contacts to describe the agreed model, 
and verify that it met the Ministry of Health guidelines. 
If the model and agreed distributors were deemed ready, 
training for HIVST distributors was scheduled for the 
following week, otherwise headman units were revisited 
1 week later.
HIVST distributors were trained over 3 days, according 
to Ministry of Health guidelines, and given an initial 
batch of 50 HIVST kits for distribution with additional 
kits available from the local clinic. Training covered infor-
mation on HIV testing, supporting others to use HIVST 
kits, providing information to promote and support 
linkage to appropriate post- test services, providing infor-
mation on effectiveness of antiretroviral therapy for 
HIV prevention, and use of data capture tools. During 
training role plays were also done to enhance distributor 
readiness for the task. Distributors were given 4–6 weeks 
to complete distribution. Headman units were asked 
to ensure that kits were given to all willing individuals 
(one kit per person) who met the testing criteria above. 
Distributors told kit recipients about post- test services 
they could access from local clinics: confirmatory testing 
for those who got reactive results and PrEP or VMMC 
for those who considered themselves at risk of HIV and 
had HIV negative self- test results (this information was 
Figure 3 Template for Intervention Description and Replication (TIDieR) table for describing the community- led and paid 
distribution HIV self- test models. ART, antiretroviral therapy; PrEP, pre- exposure prophylaxis; PSI, Population Services 
International; VMMC, voluntary medical male circumcision.
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also written on the instructions for use). Recipients of 
test kits could self- test at their convenience and did not 
need to disclose their results to distributors. All HIVST 
kits came with instructions for use in English and the two 
major local languages in Zimbabwe. In addition, distrib-
utors conducted in- person demonstration of testing 
procedures, including explanation of how to read and 
interpret the results. Our earlier work to refine self- test 
instructions for the Zimbabwean context helped ensure 
accurate testing.20 During distribution, ongoing support 
and supervision of distributors was provided by the 
local clinic. This included answering any questions and 
checking that distribution records were complete. Local 
clinics also provided kit replenishments.
Distribution by paid distributors
A detailed description of HIVST distribution by paid 
distributors according to the TIDieR framework18 is given 
in figure 3. This used a previously described model10 
(that was run in communities that were different from 
the communities in this trial) where community leader-
ship identified individuals who could distribute HIVST 
kits in their communities. Distributors received the same 
3- day training as described above, and had 4 weeks to 
cover a defined geographical area (one or two villages) 
using door- to- door distribution, with expectation that 
they would give kits to all willing individuals (one kit per 
person) in their geographical area who met the testing 
criteria. They also talked about linkage to post- test services 
as described above for distributors in the community- led 
model. PSI trained and supported distributors with kits 
and a one- off stipend of US$50.
Methods for detecting social harms during HIVST distribution
During HIVST distribution in both arms, surveillance for 
social harms was done using four methods: (1) assessment 
of reports shared by organisations providing support for 
victims of gender- based violence in the study communi-
ties, (2) reports to the toll- free number that was manned 
by PSI, (3) self- reports in the survey and, (4) reports by 
distributors.
Intervention evaluation
Four months after HIVST distribution, population- 
representative household surveys were conducted in all 
study areas. All eligible individuals (aged ≥16 years and 
resided in the study community during HIVST distribution 
in households within three enumeration areas (EAs) per 
headman unit) were asked to provide written consent for 
self- administered Audio Computer- Assisted Survey Instru-
ment (ACASI) questionnaire, with random selection used 
for headman units with ≥3 EAs. Tablet computers and head-
sets were used to enhance participant comfort and ability 
to respond freely.21 Survey questions included household 
characteristics (socioeconomic status and food security), and 
individual demographic characteristics, sexual behaviour, 
screening for common mental disorders using the Shona 
Symptom Questionnaire and Patient Health Questionnaire 
(PHQ)-2,22 23 social cohesion, history of HIV testing, uptake 
of HIV testing and HIV services such as VMMC, PrEP and 
HIV treatment. Participants in community- led arm headman 
units were also asked about whether they played any role in 
the intervention activities. In addition, we collected dried 
blood spot specimens that we tested for HIV and viral load. 
Participants could collect DBS results from the local clinic 
and receive post- test services according to local standard of 
care. Collection of results was voluntary and no follow- up was 
made in the event that people did not link.
During community- engagement meetings and HIVST 
distribution in the community- led arm, trained social science 
researchers conducted participant observations, capturing 
interactions during meetings and activities, interactions and 
community atmosphere during HIVST distribution.
Difference-in-differences substudy
This was a prespecified substudy. To assess impact of 
HIVST and the community- led intervention on ART 
initiation at local health facilities, we extracted data on 
monthly ART initiations from registers at all facilities in 
the six districts for the periods 6 months before HIVST 
distribution, during distribution and 3 months post 
distribution, collecting ART initiation data from facilities 
whose catchment areas were in either HIVST arm or that 
had had no HIVST distribution.
Costing
The full provider’s costs of delivering both interven-
tion arms observed over the full implementation period 
were analysed. The analysis combined financial costing, 
using top–down allocation of actual expenses in a step-
wise fashion to study arms activity, and sites using estab-
lished allocation factors.11 We include above service 
level costs and direct cost of service provision including 
training, self- test distribution and support and supervi-
sion. The economic costing supplemented the financial 
analysis with bottom–up costing to value donated goods 
or services, including valuing community in- kind contri-
butions. Valuation of distributor time in the paid distrib-
utor applied the value of the stipend (US$50 per distrib-
utor), in the community- led model we costed both the 
direct financial and economic (in- kind) contribution of 
the headman unit. We present total and unit cost per kit 
distributed. As the literature has shown that programme 
costs change over time, we recognise that the paid distrib-
utor arm was an established model, while the communi-
ty- led model is new. To put this in context we compare 
our costs with the costs of the paid distributor model in 
2016/2017 when it was new. All costs are presented in 
2020 US$.
Outcomes
The trial had three primary outcomes, the first two meas-
ured at the individual level based on self- report among 
survey respondents:
1. Proportion satisfying the composite outcome of self- 
reported linkage to confirmatory testing (among 
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those with a reactive (positive) self- test), VMMC or 
PrEP, among self- testers;
2. Proportion newly diagnosed with HIV, among all re-
spondents;
3. Cost per person tested with HIVST.
Statistical methods
Sample size calculation
We assumed 300 survey participants per headman unit, 
with 90% not on ART at study start. Twenty headman 
units per arm would then provide 90% power to detect 
a 40% increase in linkage from 10% in the paid distri-
bution arm to 14% in the community- led arm. Assuming 
1% of paid distribution arm survey participants reported 
newly diagnosed HIV, then 20 headman units per arm 
would provide 90% power to detect an increase to 2% 
in the community- led arm. Both sample size calculations 
assume a cluster coefficient of variation (k) of 0.25.
Data analysis
An analysis plan was finalised before data collection was 
complete. All analysis used Stata V.14. Before primary 
outcome analysis, we compared similarity by arm for 
prespecified variables to identify substantial differences 
that would need adjustment. Both primary outcomes of 
proportion (newly diagnosed HIV and linkage to post- 
test services) were analysed using mixed effect logistic 
regression with random effects adjustment for clustering 
at headman unit level. Based on identified differences, 
we adjusted for household food insecurity, religion and 
education, which were included as fixed effects in the 
adjusted model. A prespecified subgroup analysis inves-
tigated whether the effect of the community- led inter-
vention on newly diagnosed HIV and linkage outcomes 
differed by age, sex, religion, education and household 
food insecurity. Household food insecurity was assessed 
according to the Household Food Insecurity Access 
Scale.24
The first primary outcome, proportion newly diag-
nosed with HIV, was defined as first positive test plus a 
provider- confirmed positive test since the start date of 
HIVST distribution among all surveyed participants. For 
the second outcome the denominator was number of 
surveyed participants who reported testing themselves 
for HIV using a HIVST kit and not taking antiretroviral 
drugs (ARVs) at the time of testing themselves for HIV. 
The numerator was based on participant confirmation of 
taking up any of the three post- test services of confirma-
tory testing, VMMC or PrEP, following self- testing.
For the difference- in- differences study, generalised 
estimation equations were used to analyse the relation-
ship between ART initiation rates with (1) the periods 
before, during and after HIVST distribution, (2) study 
arm and (3) whether HIVST was distributed in the clinic 
catchment area for either study arm. We adjusted for 
district and calendar period. In a post- hoc analysis we 
compared ART initiation rates by distribution period 
across all health facilities regardless of whether HIVST 
were distributed locally.
Study progress was reviewed every 6 months by an inde-
pendent Technical Advisory Group.
Patient and public involvement
Before the trial we held meetings with headman units to 
get views on how community- led HIVST models could be 
planned and implemented. During trial implementation 
we worked closely with the leadership in each headman 
unit, getting their permission before activities began. At 
the end of the trial we conducted a learning event where 
we invited headman units to report on how they had 
implemented community- led HIVST and how it could be 
scaled in the future.
RESULTS
The trial (inclusive of HIVST distribution and the 
survey) was conducted between October 2018 and 
December 2019. All headman units in each arm received 
the intended treatment (figure 1) and data from all 
headman units was used in the analysis of outcomes. In 
the community- led arm 27 812 HIVST kits were distrib-
uted, with a range of 28–159 kits distributed per distrib-
utor, compared with 36 699 kits and a range of 50–375 
kits per distributor, respectively, in the paid distributor 
arm. In the community- led arm, 5 headman units opted 
to only distribute kits door- to- door, while in the other 
15 headman units kits could be collected from various 
locations including distributor homes, meeting venues 
or other locations in the headman unit. No social harms 
were reported in either arm, although 11.6% of those 
who received kits reported in the survey that they did not 
feel able to turn down the offer of the HIVST, and this 
did not differ by arm.
The post- intervention surveys included 11 150 partic-
ipants, of whom 5683 were in the community- led arm. 
The overall survey response rate was 84.5% and did 
not differ by arm. Table 1 shows the characteristics of 
surveyed participants, which were mostly similar by arm.
HIVST uptake was lower in the community- led arm: of 
surveyed participants 1205 (21.6%) took up HIVST in 
the community- led arm, compared with 1532 (27.5%) in 
the paid distributor arm, adjusted OR (aOR) 0.71 (95% 
CI 0.50 to 1.01), p=0.06.
Effect of community-led HIVST on primary outcomes
We found no difference in linkage to post- test services: in 
the community- led arm, 318 of 1229 (25.9%) of partici-
pants who used self- test kits linked to confirmatory HIV 
testing, VMMC or PrEP compared with 361 of 1508 
(23.9%) in the paid distribution arm, aOR 1.1 (0.75 to 
1.49) (table 2). The calculated k was 0.31. In the commu-
nity- led arm, 211 of 5683 (3.7%) of surveyed participants 
reported having received an HIV diagnosis after the 
first date of HIVST distribution in their headman unit, 
compared with 197 of 5467 (3.6%) in paid distributor 
arm, aOR 1.1 (0.72 to 1.56)), with k=0.51.
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Table 1 Characteristics of respondents in population- based survey
Paid distributor arm Community- led arm Total
n/n. % n/n. % n/n. %
Clusters (No.) 20 50 20 50 40 100
Households (No.) 2912 49.3 3000 50.7 5912 100
Adult household members (No.) 6442 48.8 6748 51.2 13 190 100
Mean number of adult household 
members per headman unit
322.1 337.4 329.8
Surveyed respondents (No.) 5467 49 5683 51 11 150 100
Mean number of surveyed 
respondents per headman unit
273.4 284.2 278.8
Household characteristics
Adult members per household (mean/
SD)*
2.1 (1.1) 2.2 (1) 2.1 (1.1)
Children per household (mean/SD)* 1.7 (1.6) 1.7 (1.6) 1.7 (1.6)
Household wealth quintile (n/n (%))†‡
  Poorest 1 536/2736 19.6 579/2836 20.4 1115/5572 20
  Second 2 596/2736 21.8 530/2836 18.7 1126/5572 20.2
  Middle 3 556/2736 20.3 547/2836 19.3 1103/5572 19.8
  Fourth 4 534/2736 19.5 580/2836 20.5 1114/5572 20
  Least poor 5 514/2736 18.8 600/2836 21.2 1114/5572 20
Household food insecurity (n/n (%))§
  Severe household hunger 572/2776 20.6 525/2850 18.4 1097/5626 19.5
  Moderate household hunger 951/2776 34.3 945/2850 33.2 1896/5626 33.7
  Little- to- no household hunger 1253/2776 45.1 1380/2850 48.4 2633/5626 46.8
Individual characteristics (adults only)
Age (mean/SD)¶ 35.3 (15.9) 36.0 (16.4) 35.6 (16.1)
Age in groups (n/n (%))¶
  16–24 years 1720/5464 31.5 1721/5678 30.3 3441/11 142 30.9
  25+ years 3744/5464 68.5 3957/5678 69.7 7701/11 142 69.1
  Male (n/n (%)) 2490/5467 45.5 2580/5683 45.4 5070/11 150 45.5
Marital status (n/n (%))**
  Married or living as married 3397/5394 63 3364/5601 60.1 6761/10 995 61.5
  Never married 1235/5394 22.9 1366/5601 24.4 2601/10 995 23.7
  Widowed/separated/divorced 762/5394 14.1 871/5601 15.6 1633/10 995 14.9
Highest level of education (n/n (%))
  Primary complete or less 2338/5467 42.8 2038/5683 35.9 4376/11 150 39.2
  Some secondary education 1367/5467 25 1441/5683 25.4 2808/11 150 25.2
  Secondary education complete or 
higher
1762/5467 32.2 2204/5683 38.8 3966/11 150 35.6
Religion (n/n (%))
  Apostolic 2206/5467 40.4 2055/5683 36.2 4261/11 150 38.2
  Other 3261/5467 59.6 3628/5683 63.8 6889/11 150 61.8
Receives regular salary (n/n (%))†† 1313/5401 24.3 1263/5618 22.5 2576/11 019 23.4
*120 households missing household member information in paid distributor arm and 127 in community- led arm.
†176 households missing assets data in paid distributor arm and 164 in community- led arm.
‡Ascertained at the household level using an assets index generated using principal components analysis.
§136 missing hunger information in paid distributor arm and 150 in community- led arm.
¶3 missing age in paid distributor arm and 5 in community- led arm.
**73 missing marital status in paid distributor arm and 82 in community- led arm.
††66 missing salary data in paid distributor arm and 65 in community- led arm.
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In the prespecified subgroup analysis, there was a trend 
towards better linkage to post- test services among men in 
the community- led arm with ORs of 1.28 (0.87 to 1.88) 
and 0.84 (0.57 to 1.24) among men and women, respec-
tively, interaction p=0.02 (table 3). No other differences 
were seen in the subgroup analysis.
Results from difference-in-differences study
We collected data on monthly ART initiations from 133 
clinics, including 46 with HIVST in their catchment areas, 
with a total of 1330 clinic- months of follow- up spanning 
the pre- intervention period (798 clinic months), inter-
vention period (130 clinic months) and post- intervention 
period (403 clinic months), and a total of 5302 ART 
initiations (table 4). Although the HIVST distribution 
period was associated with higher ART initiation rates, 
differences- in- differences analyses show no significant 
differences when comparing HIVST versus non- HIVST 
facilities, and a reduction in initiation rate ratio (IRR) 
when comparing community- led versus paid distributor 
arms, with interaction IRR of 1.13 (0.98–1.32), p=0.1 and 
0.76 (0.60–0.96), p=0.02, respectively, during the inter-
vention period (table 4). In post- hoc analysis, ART initi-
ations increased significantly during HIVST distribution 
across all facilities, including those not in HIVST areas, 
aOR 1.30 (1.24 to 1.37), falling to baseline levels post- 
distribution.
Costing
Total distribution costs were calculated as US$231 212 
and US$285 065 for paid distributor and communi-
ty- led programmes, respectively (online supplemental 
appendix 1). Human resources were the largest cost 
category in both model arms at 39% and 46%, followed 
by HIVST kits which contributed 37% and 23%, respec-
tively. Vehicle costs were 6% and 8% of total costs, respec-
tively. The cost per HIVST kit distributed was US$6.29 
and US$10.25 for the paid distributor arms and commu-
nity- led arms, respectively. When the paid distributor 
model was first introduced in 2016/17, the cost per 
HIVST kit distributed was $14.52.11
Across sites the cost per HIVST kit distributed ranged 
from US$5.49 to U$9.52 in the paid distributor arm 
and US$6.14 to US$33.11 in the community- led model 
arm. Unit costs were generally lower at sites with larger 
numbers of self- test kits distributed, suggesting a 
spreading of fixed costs across variable numbers of kits 
(ie, economies of scale).
DISCUSSION
In this cluster- randomised trial comparing communi-
ty- led distribution of HIVST kits against community- 
based distribution by paid distributors in 40 rural Zimba-
bwean communities (headman units), we found no 
difference in self- reported number of new HIV diagnosis 
nor self- reported linkage to post- test services (confirma-
tory testing, VMMC or PrEP). There was also no differ-
ence in ART initiation rates at health facilities in the 
study districts by HIVST distribution model, although a 
post- hoc analysis showed a 30% increase in ART initia-
tion rates during the HIVST distribution period across 
all health facilities in line with previous research from 
Zimbabwe and Malawi showing that community provi-
sion of HIVST can increase rate of ART initiations. Our 
subgroup analyses suggested that men may be more 
likely to link to post- test services in the community- led 
model. Of note, the cost per HIVST kit distributed in the 
community- led arm was US$10.25, which was higher than 
paid distribution (US$6.30). The higher cost of commu-
nity- led distribution may in part reflect inexperience with 
this distribution model, as costs in both arms were lower 
than for paid distribution of HIVST kits when first imple-
mented in 2016/2017 (US$14.52).11 Thus, as experience 
with the paid distributor model increased, implementa-
tion costs reduced by 57%.
There is evidence of the acceptability, safety and 
feasibility of community- led HIVST.25 26 The trial adds 
evidence that communities are able to organise them-
selves to design and implement context- specific HIVST 
distribution models that achieve similar rates of coverage 
and uptake to those achieved by professionally super-
vised paid distributors. Our process evaluation data 
(not presented here) suggests that most communities 
were glad to be involved and were highly motivated to 
distribute HIVST kits. It is encouraging that the cost per 
kit distributed in the community- led model was lower than 
that in the paid distributor model when first introduced. 
Table 2 Primary outcomes
Paid distributor arm Community- led arm
OR (95% CI) P valuen/n % n/n %
Primary outcome 1: self- reported linkage to confirmatory testing, PrEP and VMMC
  Unadjusted 361/1508 23.9% 318/1229 25.9% 1.1 (0.80 to 1.48) 0.6
  Adjusted 1.1 (0.75 to 1.49) 0.8
Primary outcome 2: proportion of individuals reporting a new HIV diagnosis
  Unadjusted 197/5467 3.6% 211/5683 3.7% 1 (0.69 to 1.52) 0.9
  Adjusted 1.1 (0.72 to 1.56) 0.8
PrEP, pre- exposure prophylaxis; VMMC, voluntary medical male circumcision.
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Implementation of the professionally supervised paid 
distributor model has become more efficient over time 
leading to reduced costs and it is likely that the same 
would be true of the community- led approach. Given the 
acceptability and feasibility of engaging communities to 
distribute self- test kits, and the success of other commu-
nity- led interventions13 14 27 in engaging communities to 
take ownership of their own healthcare, future research 
could evaluate using a community- led approach to layer 
a range of health and welfare activities (self- care) along-
side HIVST.
As countries get closer to achieving their UNAIDS 
Fast Track 95-95-95 targets, identifying people who are 
unaware of their status will become more difficult and 
more costly. Novel approaches and testing strategies will 
be required to efficiently reach those who have tradi-
tionally been hard to reach with testing services. Impor-
tantly, distribution of HIVST needs to be accompanied by 
ongoing efforts to promote linkage to post- test services. 
In this study distributors were trained to provide informa-
tion and encouragement for linkage when distributing 
kits. Other research has found that initiatives to promote 
linkage, such as provision of community- based services, 
can improve linkage following testing.28 The communi-
ty- led model we evaluated, which is integrated with the 
local health system, can potentially be scaled up long 
term. Costs, which are encouragingly lower than newly 
introduced paid distributor models, are likely to come 
down not only because of programme learning, but with 
use of public sector human resources, such as commu-
nity health workers (rather than the more expensive PSI 
workers) for community engagement. That the subgroup 
analysis showed a trend towards better linkage to post- 
test services in men is encouraging and suggests that this 
could be taken forward to optimise care in this group, 
whose uptake of HIV services has been known to be 
suboptimal.29
Contrary to findings from our previous studies in 
Malawi and Zimbabwe,10 we did not show a significant 
difference in ART initiation rates at health facilities whose 
catchment areas had community- based HIVST, when 
compared with those where no HIVST was distributed. 
We believe this likely reflects a much smaller unit of eval-
uation (headman unit of 500–4000 people) in this study 
than the typical health facility catchment populations. 
Thus, catchment areas where HIVST was distributed 
were only partially covered. The findings of the post- hoc 
analysis, where ART initiation rates increased during the 
HIVST distribution period across health facilities, are 
credible given the higher than expected numbers of new 
HIV diagnoses in both arms of the study (twice the 2% 
we expected during study design), which is in line with 
our previous findings of the effectiveness of HIVST in 
increasing ART initiation. This emphasises the potential 
utility of HIVST to increase status awareness.
The strengths of this study include that we evaluated an 
acceptable, feasible and potentially scalable community 
model of HIVST kit distribution that was rooted within 
the public sector system. We used robust methods in 
the design, implementation and analysis of the trial and 
difference- in- differences analysis. Limitations include 
the use of self- reports for primary outcomes, although we 
tried to minimise the self- report bias by use of ACASI. Our 
unit of implementation, the headman unit, was much 
smaller than the average health facility catchment area, 
which limited our ability to detect an effect of HIVST on 
ART initiation rates. However the trend towards increase 
in ART initiation rates as shown by the post- hoc anal-
ysis compare well with our previous findings.10 Costing 
from the provider’s perspective does not take account 
of the resources that headman units contributed to the 
successful implementation of the intervention and this 
may undermine sustainability in practice.
In summary, in this cluster randomised trial we found 
that communities can organise themselves to design and 
implement community- based HIVST distribution with 
outcomes that are comparable to programmes where 
distributors are professionally supervised and paid. The 
community- led HIVST intervention is a promising model 
that can be integrated with local standard of care and for 
scale up. The cost per HIVST kit distributed was lower 
than that for the paid distributor model when it was 
first introduced; programme costs are likely to reduce 
as programmes become embedded in communities and 
become more efficient, making the model sustainable.
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